X-Trant 140 mg Capsule (Estramustine Phosphate) Product Description: X-Trant 140 mg Capsule contains Estramustine Phosphate, a combination of an estrogen (estradiol) and a nitrogen mustard alkylating agent. It is used in the treatment of metastatic or progressive prostate cancer. The medication works by interfering with the growth of cancer cells and slowing their spread throughout the body. Manufactured by Natco Pharma Ltd, X-Trant is supplied in a bottle of 100 capsules, making it suitable for both hospital and pharmacy use. Indication: Advanced or metastatic prostate cancer Particularly effective in hormone-resistant cases Mechanism of Action: Estramustine binds to microtubule-associated proteins and inhibits mitosis in prostate cancer cells, combining cytotoxic and hormonal effects for enhanced therapeutic action. Key Features: Oral chemotherapy agent Combines hormonal and alkylating activity Supplied in bulk bottle packaging (100 capsules per bottle) Manufactured by a globally trusted oncology brand – Natco Pharma Export-ready packaging with high-quality assurance
